NCT01404000View on ClinicalTrials.gov

Treatment of Chronic Obstructive Pulmonary Disease (COPD) With Iodinated Activated Charcoal

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Chronic Obstructive Lung Disease
Interventions
DRUG

Iodinated Active Charcoal (IodoCarb)

3 g will be given as an oral suspension once daily for 56 days

Trial Locations (1)

22185

Dept of Respiratory Medcine & Allergology, Skane University Hospital, Lund

Sponsors

Lead Sponsor

PharmaLundensis AB
All Listed Sponsors
lead

PharmaLundensis AB

INDUSTRY

NCT01404000 - Treatment of Chronic Obstructive Pulmonary Disease (COPD) With Iodinated Activated Charcoal | Biotech Hunter | Biotech Hunter